002422 Sichuan Kelun Pharmaceutical
- 27.43
- -0.45-1.61%
Sichuan Kelun Pharmaceutical News
Colon Pharmaceuticals: Announcement on the completion of the sale of shares in the 2022 Employee Stock Ownership Plan
Colon Pharmaceutical: Announcement on the expected daily related transactions between the company and Shijiyao Group in 2025
Colon Pharmaceutical: “Constitution of Sichuan Colon Pharmaceutical Co., Ltd.” (December 2024)
Colon Pharmaceutical: Announcement on the expected daily related transactions between the company and Chenxin Pharmaceutical Group in 2025
Colon Pharmaceuticals: Deliberation Opinions at the Fifth Special Meeting of Independent Directors in 2024
Colon Pharmaceuticals: External Guarantee Management System (December 2024)
Colon Pharmaceuticals: Management System for the Use of Raised Funds (December 2024)
Colon Pharmaceuticals: Announcement on the estimated status of some of the company\'s daily related transactions in 2025
Colon Pharmaceuticals: Investor Relations Management System (December 2024)
Colon Pharmaceuticals: Feasibility Analysis Report on Launching Foreign Exchange Hedging Business
Colon Pharmaceutical: Announcement of Resolutions of the Fifth Meeting of the Eighth Board of Directors
Colon Pharmaceutical: Announcement on the estimated daily related transactions between the company and China Resources Colon in 2025
Colon Pharmaceuticals: Announcement on the completion of the sale of shares in the 2021 Employee Stock Ownership Plan
Colon Pharmaceuticals: Announcement on the estimated daily related transactions between the company and Colon Doosan in 2025
Colon Pharmaceuticals: Investor Relations Activity Record Form for October 29, 2024
Colon Pharmaceutical: Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Directors
Colon Pharmaceuticals: Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Supervisors
Colon Pharmaceuticals: Deliberation Opinions at the Fourth Special Meeting of Independent Directors in 2024
Colon Pharmaceuticals: Verification Opinions on Using Some Idle Funds Raised to Temporarily Replenish Liquidity
Colon Pharmaceuticals: Announcement on the use of letters of credit and own foreign exchange to pay for fund-raising project funds and replace them in equal amounts with the raised funds
No Data
